Zhang et al. successfully generated an rps19 null mutant through TALEN-mediated gene targeting, which reproduced the erythroid defects of DBA, including a lack of mature red blood cells, decreased globin synthesis, and p53 activation [35]. This evidence concerns the gene TP53 and Diamond-Blackfan anemia.